17
Total investments
14
Early stage
2
Mid stage
0
Late stage
10y
Years active
Portfolio
17 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jan 2026
Memory of users, the business, and work done. Managed, governed, and served at scale.
Investor
Sep 2025
Romix Biosciences is reinventing how disease is characterized and treated. Were building molecular tools that expand whats possible with non-invasive liquid biopsies: capturing richer, higher-dimensional insights into human health. Combined with advanced AI/ML, our platform enables new precision medicine applications and accelerates drug development.
Investor
Apr 2025
We are building the technology and industrial base to make the promise of cell-based regenerative medicine available to everyone, for every ailment.
Investor
May 2023
SaolaAI is the go-to platform for zero-maintenance, maximum-coverage testing, powered by real user behavior insights. With over 15 million user sessions recorded, Saola.ai stands at the forefront of automated end-to-end testing, trusted by hundreds of engineering teams to identify critical issues throughout the application lifecycle, ensuring top-notch product quality with ease.
Investor
Dec 2021
Vistapath is modernizing pathology labs using computer vision, automation and artificial intelligence. Despite informing a majority of clinical decisions, anatomical pathology still prepares samples for diagnosis manually, in stark contrast to other clinical lab services. Created by histotechnicians and AI experts, the Sentinel Platform makes grossing fast, efficient and easy.
Investor
Oct 2021
Robigo is an early-stage biotech leveraging CRISPR and data science to empower microbes to protect crops from disease and recover lost yields while being safe to beneficial microbes, pollinators, humans, and the environment.
Investor
Aug 2021
Turso is a Rust-based, cloud-native rewrite of SQLite, built for modern, data-driven applications. It brings async performance, improved concurrency, and the reliability of advanced testing, with the openness of true community collaboration.
Investor
Apr 2021
Powering the future with the Earth’s hidden heat.
Geothermal is carbon-free, always-on power but most of the world’s geothermal resources remain undiscovered and undeveloped.
Zanskar is changing that. We take a AI and data-driven, scalable approach to geothermal discovery and development combining modern geoscience and advanced field methods to identify and tap into overlooked or underutilized geothermal resources.
By making geothermal faster and more predictable to develop, we’re unlocking its potential to deliver gigawatts of clean, firm energy and to become a cornerstone of our future energy system.
Investor
Mar 2020
MCJ is an early-stage fund for the energy and industry transition and the inevitable impacts of climate change. We discover and invest in startups rewriting industries to be cleaner, more profitable, and more resilient. We strengthen our investments through the MCJ Collective — a vetted member network that connects talented tech and industrial leaders with our portfolio and with one another. Our media platform, including the Inevitable podcast, spotlights key perspectives critical to our portfolio and the transition at large, reaching tens of thousands of professionals multiple times per week.
Founding Investor
Jan 2020
Make weather-related decisions in time to matter. Reliable, award-winning 2- to 52-week forecasts for adapting to a more volatile climate.
Investor
Nov 2019
We make oceans manageable, insurable and investable.
Scoot Science is the ocean company.
What's happening beneath the surface doesn't have to be a mystery. Scoot Science fills in the data gaps, and then uses a combination of traditional numerical ocean models and predictive artificial intelligence to deliver accurate underwater weather.
What can Scoot Science do for your marine operations?
* Visualize - Wake up each day to the headlines of your underwater weather and a complete picture of the local sub-surface conditions
*Analyze - Know the environmental threats to your marine operations before the impacts materialize
* Empower - Make informed logistics and operations decisions, protect your marine assets and strengthen your bottom line
Investor
Sep 2019
Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and at high throughput. The nELISA was designed to seamlessly integrate into current workflows in biology and is uniquely adaptable to a wide variety of use cases within drug and biomarker development workflows. Nomic is headquartered in Montreal, with labs and offices in Boston. For more information, visit www.nomic.bio.
Investor
Aug 2019
Oort, now part of Cisco, has fully transitioned into Cisco. The acquisition closed in July 2023.
Cisco Identity Intelligence, formerly Oort, is an AI-powered solution that bridges the gap between authentication and access, providing top-tier security insights without interruptions.
Protect your attack surface
By closing the gaps between authentication and access, Cisco Identity Intelligence solution protects your attack surface before attackers can make their move.
Deep visibility
Get a full picture of identity activity and clean up vulnerable accounts, eliminate risky privileges, and block high-risk access attempts.
Better together.
With seamless deployment, Cisco Identity Intelligence solution powers other Cisco security suites, resulting in deeper functionality that informs the right response to any threat.
Built to scale and protect
Attackers methods are becoming increasingly more complex, which is why Cisco Identity Intelligence solution is built to protect your organization against identity threats, no matter how sophisticated they are.
Investor / Board Observer
Jul 2018
Locked in your company’s data is value waiting to be freed through new products, insights, or partnerships. Tranquil Data unlocks that value by connecting data to its context, accelerating platform adoption and enabling new uses for existing data.
Capturing Context on Ingest:
Data flows from systems of record to common data platforms in order to surface new insights and opportunities. This creates value but also invites risk by disconnecting data from its context, which is needed to answer questions like why you have data or what you’re allowed to do with it.
Tranquil Data automates the process of connecting your data to its context, simplifying compliance, and empowering agile analysis, innovation, and transformation.
Harnessing Context to Qualify Derived Uses:
For data platforms to increase their value, they must aggregate increasingly valuable data, often across new demographics, geographies, or partnerships. For compliance and legal teams to approve this level of risk, they need to be certain that enrichment and analysis meets all relevant obligations.
Tranquil Data tracks the business agreements and properties governing your data, making it possible to discover and validate new uses for existing data.
Operationalizing Context to Accelerate Value:
Data analysis leads to business insight, used to create new products or enhanced collaborations. Value from those products or partners is only maximized by enforcing agreements and ensuring that any resulting data can flow seamlessly back into the data platforms.
Tranquil Data validates applications or ETL pipelines against business requirements, accelerating development and surfacing lineage, making business properties observable and providing quality for future use.
Investor
Jul 2017
Jellyfish is the pioneer Engineering Management Platform that enables engineering leaders to align engineering work with strategic business objectives. By analyzing engineering signals and contextual business data, Jellyfish provides complete visibility into engineering organizations, the work they do, and how they operate. Companies like SessionM (A Mastercard Company) and Toast use Jellyfish to optimize the allocation of engineering resources to focus their teams on what matters most to the business.
Show all 17 investments ↓
Experience · 20 entries
All (20)
Investments (17)
Founder (2)
Board (2)
2026
Investor
Jan 2026
Memory of users, the business, and work done. Managed, governed, and served at scale.
2025
Investor
Sep 2025
Romix Biosciences is reinventing how disease is characterized and treated. Were building molecular tools that expand whats possible with non-invasive liquid biopsies: capturing richer, higher-dimensional insights into human health. Combined with advanced AI/ML, our platform enables new precision medicine applications and accelerates drug development.
Investor
Apr 2025
We are building the technology and industrial base to make the promise of cell-based regenerative medicine available to everyone, for every ailment.
2023
Investor
May 2023
SaolaAI is the go-to platform for zero-maintenance, maximum-coverage testing, powered by real user behavior insights. With over 15 million user sessions recorded, Saola.ai stands at the forefront of automated end-to-end testing, trusted by hundreds of engineering teams to identify critical issues throughout the application lifecycle, ensuring top-notch product quality with ease.
2021
Investor
Dec 2021
Vistapath is modernizing pathology labs using computer vision, automation and artificial intelligence. Despite informing a majority of clinical decisions, anatomical pathology still prepares samples for diagnosis manually, in stark contrast to other clinical lab services. Created by histotechnicians and AI experts, the Sentinel Platform makes grossing fast, efficient and easy.
Show all 20 entries ↓
Investment activity
2016–2026 · 17 investments
Recent (last 2 years)Earlier
